These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35759355)

  • 41. Long-Term Efficacy of Bariatric Surgery for the Treatment of Super-Obesity: Comparison of SG, RYGB, and OAGB.
    Soong TC; Lee MH; Lee WJ; Almalki OM; Chen JC; Wu CC; Chen SC
    Obes Surg; 2021 Aug; 31(8):3391-3399. PubMed ID: 33993423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Isotachophoretic determination of desloratadine in tablets and syrup].
    Kubacák P; Mikus P; Valásková I; Havránek E
    Ceska Slov Farm; 2005 Nov; 54(6):266-9. PubMed ID: 16383190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling - case example dipyridamole.
    Segregur D; Barker R; Mann J; Moir A; Karlsson EM; Turner DB; Arora S; Dressman J
    Eur J Pharm Sci; 2021 May; 160():105750. PubMed ID: 33581261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of antiallergic treatment with desloratadine-montelukast on salivary glands function in allergic rhinitis.
    Ayan A; Yoruk O; Seven B; Orsal E; Mutlu V; Aydin B
    Hell J Nucl Med; 2014; 17(3):190-3. PubMed ID: 25397624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanosized-Loratadine Embedded Orodispersible Films for Enhanced Bioavailability: Scalable Preparations and Characterizations.
    Van Nguyen K; Nguyen HT; Nghiem LHT; Van Can M; Tran TH
    AAPS PharmSciTech; 2022 Feb; 23(3):78. PubMed ID: 35194702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery.
    Porat D; Azran C; Kais H; Dahan A
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
    Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
    Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once in a Bile - the Incidence of Bile Reflux Post-Bariatric Surgery.
    Eldredge TA; Bills M; Ting YY; Dimitri M; Watson MM; Harris MC; Myers JC; Bartholomeusz DL; Kiroff GK; Shenfine J
    Obes Surg; 2022 May; 32(5):1428-1438. PubMed ID: 35226339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug.
    Okumu A; DiMaso M; Löbenberg R
    Pharm Res; 2008 Dec; 25(12):2778-85. PubMed ID: 18560996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biorelevant in vitro Tools and in silico Modeling to Assess pH-Dependent Drug-drug Interactions for Salts of Weak Acids: Case Example Potassium Raltegravir.
    Segregur D; Mann J; Moir A; Karlsson EM; Dressman J
    J Pharm Sci; 2022 Feb; 111(2):517-528. PubMed ID: 34597624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
    Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
    AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling.
    Radwan A; Jayyousi R; Shraim N; Zaid AN
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):121-134. PubMed ID: 30891805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
    Bachert C; Maurer M
    Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A physiologically-based drug absorption modeling for orally disintegrating tablets.
    Kambayashi A; Kiyota T
    Eur J Pharm Biopharm; 2020 Jul; 152():1-9. PubMed ID: 32371153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.
    Musella M; Apers J; Rheinwalt K; Ribeiro R; Manno E; Greco F; Čierny M; Milone M; Di Stefano C; Guler S; Van Lessen IM; Guerra A; Maglio MN; Bonfanti R; Novotna R; Coretti G; Piazza L
    Obes Surg; 2016 May; 26(5):933-40. PubMed ID: 26341086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conversion from laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) to one anastomosis gastric bypass (OAGB): preliminary data from a multicenter retrospective study.
    Musella M; Bruni V; Greco F; Raffaelli M; Lucchese M; Susa A; De Luca M; Vuolo G; Manno E; Vitiello A; Velotti N; D'Alessio R; Facchiano E; Tirone A; Iovino G; Veroux G; Piazza L
    Surg Obes Relat Dis; 2019 Aug; 15(8):1332-1339. PubMed ID: 31272866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.